Content about Pharmaceutical companies

April 22, 2012
Consumer care

A lot has happened across GlaxoSmithKline’s consumer division in the past year. Drug Store News spoke with GSK Consumer chief marketing officer John Graham and chief customer officer Keith Loranger about the next move to be made out of the consumer division’s new playbook.

May 21, 2012
GSK, Auxilium to co-promote testosterone therapy

The U.S. subsidiary of British drug maker GlaxoSmithKline and U.S.-based Auxilium Pharmaceuticals will co-promote a testosterone-replacement drug, the two said Monday.

May 18, 2012
Dr. Reddy's launches generic version of Plavix

Generic drug maker Dr. Reddy's Labs has launched a generic version of a drug used to prevent clotting of the blood.

May 18, 2012
FDA approves generic Parkinson's disease drug made by Actavis

The Food and Drug Administration has approved a treatment for Parkinson's disease made by Actavis, the drug maker said Friday.

May 18, 2012
Watson challenges Lo Loestrin Fe patent

Generic drug maker Watson Pharmaceuticals is challenging the patent protection of a contraceptive drug made by Warner Chilcott, Watson said Friday.

May 17, 2012
FDA approves generic versions of Plavix

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 17, 2012
Sagent launches generic chemotherapy drug

Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.

May 16, 2012
Amneal adds blackberry flavoring to generic diabetes drug

Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.

May 16, 2012
ReportersNotebook — Chain Pharmacy, 5/21/12

Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.

May 15, 2012
GSK to buy up research and development company

GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.

May 15, 2012
Product launches, Cephalon acquisition drive Teva's Q1 revenues

Net revenues for Teva rose more than 24% for the first quarter ended March 31, thanks to new drug launches and the company's acquisition of drug maker Cephalon.

May 15, 2012
Reports: Pfizer 'quietly' giving up on Lipitor marketing

Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

May 11, 2012
Amgen offers testimony at FDA biosimilars hearing

Biotech drug maker Amgen has joined the list of companies offering testimony at a Food and Drug Administration hearing on biosimilars Friday.

May 10, 2012
FDA panel recommends approval for Pfizer RA drug

A Food and Drug Administration expert panel has recommended approval for a drug made by Pfizer for treating rheumatoid arthritis.

May 10, 2012
New office to help integrate Actavis into Watson

Generic drug maker Watson Pharmaceuticals has formed a special office to handle its pending acquisition of Actavis, the company said.

May 10, 2012
Watson seeks approval for generic ulcerative colitis drug

Generic drug maker Watson Pharmaceuticals is hoping to be the first to market a generic version of a drug used to treat ulcerative colitis, the company said.

May 8, 2012
Reports: Court upholds Abilify patent

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

May 7, 2012
Purdue Pharma launches free educational resource to combat drug abuse

Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.

May 2, 2012
Sandoz acquires Fougera for $1.5 billion

Novartis' generics division has acquired Fougera Pharmaceuticals, the company said Wednesday.

April 30, 2012
Mylan to launch generic version of Nuvigil in 2016

Mylan plans to start selling a generic version of a drug for sleep disorders starting in June 2016, under a deal with Teva announced Monday.

April 27, 2012
Mylan, Pfizer, Teva reach deal over generic version of EpiPen

Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

April 26, 2012
FDA declines to approve Takeda diabetes drug

The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.

April 26, 2012
Watson to buy Actavis for $5.6 billion

Watson has announced its intention to acquire Actavis, the company said.

April 25, 2012
Amgen to buy Turkish drug maker for $700 million

Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.

April 25, 2012
Reports: GSK calls $2.6 billion offer for Human Genome Sciences 'full and fair'

GlaxoSmithKline said its offer to buy Human Genome Sciences was "full and fair" Wednesday after HGS turned it down last week, according to published reports.

© 2012 Drug Store News. All Rights Reserved.